NEUROCRINE BIOSCIENCES INC
Biological Products, (No Diagnostic Substances) · 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA 92130
官方登記資料
0位追蹤者
1992成立於
關於 NEUROCRINE BIOSCIENCES INC
Neurocrine Biosciences, Inc. is an American biopharmaceutical company founded in 1992. It is headquartered in San Diego, California, and led by CEO Kyle Gano as of October 11, 2024. Neurocrine develops treatments for neurological and endocrine-related diseases and disorders. In 2017, the company's drug valbenazine (Ingrezza) was approved in the US to treat adults with tardive dyskinesia (TD).
Source: Wikipedia
產業Biological Products, (No Diagnostic Substances)
總部6027 EDGEWOOD BEND COURT, SAN DIEGO, CA 92130
成立時間1992
法律形式C Corporation
狀態營運中
專利52 項專利
SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYLPHENYL)-N-[(1S)-2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)ETHYL]-5-METHYL…JP2025157396A · 2025
METHODS FOR ADMINISTRATION OF CERTAIN VMAT2 INHIBITORSJP2025146959A · 2025
關鍵數據
法律資訊
| 法定名稱 | NEUROCRINE BIOSCIENCES INC |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 914475在 SEC EDGAR 上查看 ↗ |
| EIN | 33-0525145 |
| 產業代碼(SIC) | 2836 |
| 登記地址 | 6027 EDGEWOOD BEND COURT, SAN DIEGO, CA 92130 |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年10月15日
聯絡方式與連結
地點
6027 EDGEWOOD BEND COURT, SAN DIEGO, CA 92130
這是你的公司嗎?
免費認領此頁面,即可新增標誌、產品、照片與職缺,並回覆評論。
認領此頁面